| SWOG/ Support |
STUDY | R E G |
O P E N |
ARM | ACCR. GOAL |
TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SWOG | S2206-Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | Y | 1 Tissue for MammaPrint testing | 960 | 1154 | 521 | 260 | 107 | 37 | 3 | 11/27/2023 | 389 | 128 |
| 1154 | 521 | 260 | 107 | 37 | 3 | |||||||||
| 2 | Y | 2 SOC Chemotherapy | 206 | 96 | 48 | 20 | 8 | 1 | 11/27/2023 | |||||
| 3 SOC Chemotherapy + Durvalumab | 197 | 89 | 43 | 12 | 3 | 1 | ||||||||
| 403 | 185 | 91 | 32 | 11 | 2 | |||||||||
| S2212-Breast, TNBC, Neoadj Chemo + Pembro | 1 | Y | 1 Carbo + Paclitaxel + Pembro -> AC + Pembro | 2400 | 802 | 400 | 219 | 106 | 37 | 9 | 09/15/2023 | 441 | 160 | |
| 2 Carbo + Docetaxel + Pembro | 799 | 393 | 218 | 100 | 35 | 7 | ||||||||
| 1601 | 793 | 437 | 206 | 72 | 16 | |||||||||
| Yes | A011801-BRST, HER2+, T-DM1+Placebo v T-DM1+Tucatinib | 1 | E | Total Registrations | 55 | 0 | 0 | 0 | 0 | 0 | 03/11/2021 | 460 | 190 | |
| 55 | 0 | 0 | 0 | 0 | 0 | |||||||||
| A012103-Breast,StgT1cN1-2/T2-4N0-2,obsvsPembrolizumab | 1 | E | Total Registrations | 65 | 29 | 18 | 12 | 5 | 1 | 08/24/2023 | 449 | 198 | ||
| 65 | 29 | 18 | 12 | 5 | 1 | |||||||||
| NRGBR002-Brst, OMBC, II-III, SoC +/- SBRT and/or SA | 1 | T | Total Registrations | 1 | 0 | 0 | 0 | 0 | 0 | 09/22/2017 | ||||
| 1 | 0 | 0 | 0 | 0 | 0 | |||||||||
| NRGBR005-Br, Stg II&IIIA, Post NAdj Chemo Br Conserv | 1 | T | Total Registrations | 7 | 0 | 0 | 0 | 0 | 0 | 06/22/2018 | ||||
| 7 | 0 | 0 | 0 | 0 | 0 | |||||||||
| No | A012303-Breast, HER2+, Shortened Adj | 1 | E | Total Registrations | 5 | 5 | 5 | 2 | 0 | 0 | 03/06/2026 | 71 | 25 | |
| 5 | 5 | 5 | 2 | 0 | 0 | |||||||||
| NRGBR009-Breast, EarlyStg, Adjuvant Chemo | 1 | E | Total Registrations | 58 | 41 | 16 | 7 | 3 | 1 | 01/31/2024 | 515 | 197 | ||
| 58 | 41 | 16 | 7 | 3 | 1 | |||||||||
| 2 | E | Total Registrations | 44 | 28 | 11 | 2 | 0 | 0 | 01/31/2024 | |||||
| 44 | 28 | 11 | 2 | 0 | 0 | |||||||||